David Church
Professor
- Cancer Research UK Senior Cancer Research Fellow
- Honorary Consultant in Medical Oncology
Research focus
We study the mechanisms underpinning the growth and suppression of bowel and womb cancers, focusing particularly on the immune response tumours induce and evade. We aim to identify new biomarkers and targets to better prevent and treat these common diseases
Key publications
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study.
Journal article
Wagner SJ. et al, (2023), Cancer cell, 41, 1650 - 1661.e4
Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis
Journal article
Colling R. et al, (2015), Journal of Clinical Pathology, 68, 1036 - 1039
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
Journal article
van Gool IC. et al, (2015), Clinical Cancer Research, 21, 3347 - 3355
Recent publications
Image-Based Consensus Molecular Subtyping Refines Prognostication in Stage II/III Colorectal Cancer: A Retrospective Analysis of the SCOT Trial.
Journal article
Lafarge MW. et al, (2026), J Clin Oncol
A regenerative stem cell phenotype marked by ANXA1 defines aggressive colorectal cancer biology
Preprint
Rotte H. et al, (2026)
CD4+ T cell-licensed CD8+ T cells are required for immunotherapy response in MHC-I negative MMRd cancer.
Journal article
Requesens M. et al, (2026), EMBO Mol Med